These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26463914)

  • 21. Hyperosmolar Therapy in Pediatric Severe Traumatic Brain Injury-A Systematic Review.
    Stopa BM; Dolmans RGF; Broekman MLD; Gormley WB; Mannix R; Izzy S
    Crit Care Med; 2019 Dec; 47(12):e1022-e1031. PubMed ID: 31567404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperosmolar therapy: A century of treating cerebral edema.
    Desai A; Damani R
    Clin Neurol Neurosurg; 2021 Jul; 206():106704. PubMed ID: 34045110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperosmolar therapy for raised intracranial pressure.
    Benardete EA
    N Engl J Med; 2012 Dec; 367(26):2556; author reply 2556-7. PubMed ID: 23268681
    [No Abstract]   [Full Text] [Related]  

  • 24. Hyperosmolar therapy for raised intracranial pressure.
    Moritz ML; Ayus JC
    N Engl J Med; 2012 Dec; 367(26):2555-6; author reply 2556-7. PubMed ID: 23268680
    [No Abstract]   [Full Text] [Related]  

  • 25. Hyperosmolar therapy for raised intracranial pressure.
    Huh JW; Priestley MA; Dominguez TE
    N Engl J Med; 2012 Dec; 367(26):2555; author reply 2556-7. PubMed ID: 23268679
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperosmolar therapy for raised intracranial pressure.
    Misra UK; Kalita J; Goyal G
    N Engl J Med; 2012 Dec; 367(26):2554-5; author reply 2556-7. PubMed ID: 23268678
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study.
    Kerwin AJ; Schinco MA; Tepas JJ; Renfro WH; Vitarbo EA; Muehlberger M
    J Trauma; 2009 Aug; 67(2):277-82. PubMed ID: 19667879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study on the efficacy of 10% hypertonic saline and equal volume of 20% mannitol in the treatment of experimentally induced cerebral edema in adult rats.
    Zeng HK; Wang QS; Deng YY; Jiang WQ; Fang M; Chen CB; Jiang X
    BMC Neurosci; 2010 Dec; 11():153. PubMed ID: 21143951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.
    Cook AM; Morgan Jones G; Hawryluk GWJ; Mailloux P; McLaughlin D; Papangelou A; Samuel S; Tokumaru S; Venkatasubramanian C; Zacko C; Zimmermann LL; Hirsch K; Shutter L
    Neurocrit Care; 2020 Jun; 32(3):647-666. PubMed ID: 32227294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salt or sugar on the brain: does it matter except for taste?
    Stubbe HD
    Crit Care Med; 2011 Mar; 39(3):601-2. PubMed ID: 21330867
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of hypertonic saline in exercise-induced hyponatremia.
    Srivali N; Laohaphan V; Hosiriluck N
    Am J Emerg Med; 2014 Nov; 32(11):1424. PubMed ID: 25200506
    [No Abstract]   [Full Text] [Related]  

  • 32. Current status of osmotherapy in intracerebral hemorrhage.
    Kalita J; Ranjan P; Misra UK
    Neurol India; 2003 Mar; 51(1):104-9. PubMed ID: 12865537
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials.
    Kamel H; Navi BB; Nakagawa K; Hemphill JC; Ko NU
    Crit Care Med; 2011 Mar; 39(3):554-9. PubMed ID: 21242790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of equiosmolar dose of hyperosmolar agents in reducing intracranial pressure-a randomized control study in pediatric traumatic brain injury.
    Kumar SA; Devi BI; Reddy M; Shukla D
    Childs Nerv Syst; 2019 Jun; 35(6):999-1005. PubMed ID: 30879126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing use of hypertonic saline over mannitol in the treatment of symptomatic cerebral edema in pediatric diabetic ketoacidosis: an 11-year retrospective analysis of mortality*.
    Decourcey DD; Steil GM; Wypij D; Agus MS
    Pediatr Crit Care Med; 2013 Sep; 14(7):694-700. PubMed ID: 23863818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mannitol: an old friend on the skids?
    Prough DS; Zornow MH
    Crit Care Med; 1998 Jun; 26(6):997-8. PubMed ID: 9635644
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperosmolar therapy for raised intracranial pressure.
    Ropper AH
    N Engl J Med; 2012 Aug; 367(8):746-52. PubMed ID: 22913684
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebral edema before onset of therapy in newly diagnosed type 2 diabetes.
    Morales AE; Daniels KA
    Pediatr Diabetes; 2009 Apr; 10(2):155-7. PubMed ID: 19261103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The internal environment and intracranial hypertension].
    Ichai C; Ciais JF; Grimaud D
    Ann Fr Anesth Reanim; 1997; 16(4):435-44. PubMed ID: 9750595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenging the gold standard: should mannitol remain our first-line defense against intracranial hypertension?
    Infanti JL
    J Neurosci Nurs; 2008 Dec; 40(6):362-8. PubMed ID: 19170304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.